Component: (Network and Table)
Network
00300 - Statement - Consolidated Balance Sheets
(http://www.clovisoncology.com/role/StatementConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001466301 (http://www.sec.gov/CIK)
Consolidated Balance SheetsPeriod [Axis]
2016-12-31
2015-12-31
Consolidated Balance Sheets
 
 
ASSETS
 
 
Current assets:
 
 
Cash and cash equivalents
216,186,000  
278,756,000  
Accounts receivable
121,000  
0  
Available-for-sale securities
49,997,000  
249,832,000  
Prepaid research and development expenses
6,427,000  
3,377,000  
Other current assets
6,679,000  
7,736,000  
Total current assets
279,410,000  
 
539,701,000  
 
Property and equipment, net
4,440,000  
4,946,000  
Intangible assets, net
21,047,000  
101,500,000  
Goodwill
57,192,000  
59,327,000  
Other assets
2,468,000  
7,912,000  
Total assets
364,557,000  
 
713,386,000  
 
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
 
 
Current liabilities:
 
 
Accounts payable
10,912,000  
11,260,000  
Accrued research and development expenses
35,198,000  
53,011,000  
Other accrued expenses
19,487,000  
11,305,000  
Total current liabilities
65,597,000  
 
75,576,000  
 
Contingent purchase consideration
0  
24,661,000  
Deferred income taxes, net
0  
31,133,000  
Milestone liability
20,062,000  
0  
Convertible senior notes
281,126,000  
279,885,000  
Deferred rent, long-term
1,406,000  
1,481,000  
Total liabilities
368,191,000  
 
412,736,000  
 
Commitments and contingencies (Note 10)
xsi:nil  
xsi:nil  
Stockholders' equity:
 
 
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized, no shares issued and outstanding at December 31, 2016 and December 31, 2015
xsi:nil  
xsi:nil  
Common stock, $0.001 par value per share, 100,000,000 shares authorized at December 31, 2016 and December 31, 2015; 38,724,090 and 38,359,454 shares issued and outstanding at December 31, 2016 and December 31, 2015 respectively
39,000  
38,000  
Additional paid-in capital
1,174,950,000  
1,129,978,000  
Accumulated other comprehensive loss
(47,580,000) 
(47,460,000) 
Accumulated deficit
(1,131,043,000) 
(781,906,000) 
Total stockholders' (deficit) equity
(3,634,000) 
 
300,650,000  
 
Total liabilities and stockholders' (deficit) equity
364,557,000  
 
713,386,000